Miconazole warnings and precautions

Revision as of 09:00, 9 January 2014 by Ahmed Zaghw (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Miconazole
Oravig® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Warnings and Precautions

Hypersensitivity

Allergic reactions, including anaphylactic reactions and hypersensitivity, have been reported with the administration of miconazole products, including ORAVIG®.

Discontinue ORAVIG® immediately at the first sign of hypersensitivity.

There is no information regarding cross-hypersensitivity between miconazole and other azole antifungal agents.

Monitor patients with a history of hypersensitivity to azoles.[1]

References

  1. "ORAVIG (MICONAZOLE) TABLET [PRAELIA PHARMACEUTICALS INC]".

Adapted from the FDA Package Insert.